TrappBDPetersonJRansohoffRM. Axonal transection in the lesions of multiple sclerosis. N Engl J Med1998; 338: 278–285.
2.
TripSASchlottmannPGJonesSJ. Retinal nerve fibre layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol2005; 58: 383–391.
3.
ScalfariANeuhausADegenhardtA. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain2010; 133: 1914–1929.
4.
KatzDTaubenbergerJKCannellaB. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol1993; 34: 661–669.
5.
SormaniMPBonzanoLRoccatagliataL. Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach. Ann Neurol2009; 65: 268–275.
6.
FisnikuLKBrexPAAltmannDR. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain2008; 131: 808–817.
7.
LiDLiDKHeldU. MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology2006; 66: 1384–1389.
8.
MillerDHAltmannDRChardDT. Advances in imaging to support the development of novel therapies for multiple sclerosis. Clin Pharmacol Therapeut2012, [in press].
